Cold Snare Piecemeal Resection vs Cold Snare Endoscopic Mucosal Resection
Launched by INDIANA UNIVERSITY · Jun 12, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. ≥ 18 years of age
- • 2. Presenting for a screening, surveillance, diagnostic, or therapeutic colonoscopy
- 3. Found to have:
- • a sessile serrated lesion or hyperplastic polyp ≥ 10 mm during procedure (Serrated Cohort) or
- • a 10-19 mm conventional adenoma during procedure (Adenoma Cohort)
- • 4. Ability to provide informed consent
- Exclusion Criteria:
- • 1. Pedunculated or semi-pedunculated polyps (as defined by Paris Classification type Ip or Isp)
- 2. Polyps confirmed to be anything other than:
- • sessile serrated lesion or hyperplastic polyp on histologic diagnosis (Serrated Cohort) or
- • conventional adenoma on histologic diagnosis (Adenoma Cohort)
- • 3. Patients with Ulcerative Colitis or Crohn's disease
- • 4. Polyps with features suggestive of submucosal invasion
- • 5. Polyps that are not able to be removed endoscopically due to location (e.g. extending into appendiceal orifice or diverticulum)
- 6. Patients with a known or suspected diagnosis of any of the following polyposis syndromes with known genetic mutations:
- • Familial Adenomatous Polyposis Syndrome
- • MUTYH associated Polyposis Syndrome
- • Juvenile Polyposis Syndrome
- • Cowden's Syndrome
- • Peutz-Jeghers Syndrome
- • 7. Subjects whose colonoscopy procedure is not able to be completed due to bowel prep precluding polyp identification.
About Indiana University
Indiana University, a leading research institution, is committed to advancing healthcare through innovative clinical trials and rigorous scientific inquiry. With a focus on improving patient outcomes, the university conducts a wide range of studies across various medical disciplines, leveraging its extensive resources and collaborative networks. Indiana University's dedication to ethical research practices and community engagement ensures that its clinical trials not only contribute to scientific knowledge but also prioritize participant safety and well-being. Through its commitment to excellence, Indiana University plays a pivotal role in shaping the future of medicine and enhancing public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Indianapolis, Indiana, United States
Patients applied
Trial Officials
John J Guardiola, MD
Principal Investigator
Indiana University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported